Itraconazole as a Targeted Therapy for Inhibiting Hedgehog Pathway Signaling in Esophageal Cancer Patients
Condition(s):Esophageal CancerLast Updated:November 4, 2021Unknown status
Hide Studies Not Open or Pending
Condition(s):Esophageal CancerLast Updated:November 4, 2021Unknown status
Condition(s):OnychomycosisLast Updated:October 19, 2022Completed
Condition(s):HealthyLast Updated:May 25, 2022Completed
Condition(s):HealthyLast Updated:July 3, 2023Completed
Condition(s):Hematologic Neoplasms; Neutropenia; FeverLast Updated:August 12, 2013Completed
Condition(s):Healthy ParticipantsLast Updated:June 28, 2019Completed
Condition(s):Basal Cell Carcinoma (BCC); Skin CancerLast Updated:November 13, 2018Completed
Condition(s):Healthy Adult SubjectsLast Updated:November 13, 2020Completed
Condition(s):Breast Neoplasms; Neoplasm MetastasisLast Updated:December 21, 2023Completed
Condition(s):Pulmonary Disease, Chronic ObstructiveLast Updated:April 27, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.